2028年までの中東およびアフリカの脳がん診断市場予測 - 新型コロナウイルス感染症の影響と診断タイプ別の地域分析(画像検査、腰椎穿刺、生検、分子検査など)。がんの種類(聴神経腫、星状細胞腫、頭蓋咽頭腫、神経節神経腫、多形膠芽腫、髄膜腫、上衣腫など);エンドユーザー (病院、専門クリニック、外来手術センターなど)

TIPRE00025900 | Pages: 152 | Medical Device | Nov 2021 | Type: Regional | Status: Published

市場紹介

脳がんは、腫瘍を引き起こす脳内の細胞の細胞外増殖によって引き起こされます。腫瘍には原発性脳腫瘍と続発性脳腫瘍が含まれます。原発性脳腫瘍は脳内で形成され、体の他の部分には広がりませんが、二次腫瘍(転移とも呼ばれます)は体の別の部分で発生したがんです。 脳腫瘍は 40 の主要なタイプに分類され、さらに 2 つの主要なグループに分類されます。1 つは良性、つまり成長が遅く転移する可能性が低いもの、悪性、つまり癌性で転移する可能性が高いものです。

< p>したがって、脳腫瘍の有病率の増加により、今後数年間で脳腫瘍診断に対する大きな需要が生み出されると予想され、それが脳腫瘍診断市場をさらに牽引すると予想されます。

パンデミックは原因となったものです。世界中の医療サービスに混乱が生じ、脳腫瘍などの重大な症状に各国が対処し、対応する能力に影響を与えています。多くの国で診断サービスが中断され、主要商品のサプライチェーンが寸断されている。アフリカでは、新型コロナウイルス感染症(COVID-19)が脳腫瘍を含む主要な健康状態の制御を脅かしている。新型コロナウイルス感染症(COVID-19)がアフリカで蔓延し続ける中、市場への影響、診断の制限、専門の神経外科医へのアクセスの減少が、同地域の市場にさらに影響を与えるのではないかと懸念されている。しかし、パンデミックの状況が克服されるにつれて、脳腫瘍の診断に使用されるいくつかの診断手段の需要は増加するでしょう。

 

< p>市場の概要とダイナミクス

中東およびアフリカの脳腫瘍診断市場は、2021 年の 8,740 万米ドルから米国に成長すると予想されています。 2028年までに2億3,700万ドル。 2021 年から 2028 年にかけて 15.3% の CAGR で成長すると推定されています。「原発性脳腫瘍」という用語は、脳で発生する腫瘍を指します。脳および神経系のがんは、男性および女性の死亡原因の第 10 位にあります。人の生涯において、この形態の腫瘍が発生する可能性は 1% 未満です。原発性中枢神経系 (CNS) 悪性腫瘍のほとんどは脳腫瘍であり、全症例の 85% ~ 90% を占めます。脳腫瘍は致命的となる可能性があり、生活の質に深刻な影響を及ぼし、最終的には患者とその家族の生活を一変させます。さらに、腫瘍の早期発見により、より多くの治療選択肢が得られることがよくあります。高度な画像技術により、脳腫瘍の位置を正確に特定できます。診断ツールには、磁気共鳴画像法 (MRI) およびコンピューター断層撮影 (CT または CAT スキャン) が含まれます。術中 MRI は、手術中の組織生検や腫瘍切除のガイドにも使用できます。磁気共鳴分光法 (MRS) は、腫瘍の化学的特徴を調べるために使用されます。したがって、脳腫瘍の有病率の増加により、脳腫瘍の診断ツールが強く求められています。     

 

主要市場セグメント

用語診断の種類別では、画像検査セグメントが2020年の中東およびアフリカの脳腫瘍診断市場で最大のシェアを占めました。がんの種類に関しては、多形神経膠芽腫セグメントが中東およびアフリカの脳腫瘍診断で最大のシェアを占めました。エンドユーザーの観点から見ると、2020 年の中東およびアフリカの脳腫瘍診断市場で病院セグメントが最大のシェアを占めました。

 

記載されている主要な情報源と企業

このレポートを作成するために参照されたいくつかの主要な一次および二次情報源中東とアフリカの脳腫瘍診断市場には、企業のウェブサイト、年次報告書、財務報告書、政府文書、統計データベースなどが含まれます。このレポートに記載されている主要企業は、Thermo Fisher Scientific Inc.、Siemens Healthineers A、GE Healthcare、Biocept, Inc.、Koninklijke Philips NV、Canon Medical Systems、Hitachi, Ltd.、Neusoft Medical Systems です。

 

理由レポートを購入する

  • 中東およびアフリカの脳腫瘍診断市場の状況を理解し、最も成長する可能性が高い市場セグメントを特定します。強力なリターンを保証する
  • 中東およびアフリカの脳腫瘍診断市場の絶え間なく変化する競争環境を理解し、競争に先んじる
  • 中東およびアフリカにおけるM&Aおよびパートナーシップ取引を効率的に計画する最も売上が見込まれる市場セグメントを特定することにより、東およびアフリカの脳がん診断市場
  • 中東およびアフリカの脳がん診断市場のさまざまなセグメントの市場パフォーマンスの知覚的かつ包括的な分析から、知識に基づいたビジネス上の意思決定を行うのに役立ちます
  • 2021 年から 2028 年までの中東およびアフリカ地域のさまざまなセグメント別の市場収益予測を取得します

 

中東およびアフリカの脳腫瘍診断市場セグメンテーション

 

診断タイプ別

  • 画像検査
    • MRI
    • CT スキャン
    • PET
  • 生検
  • 分子検査
  • 腰椎穿刺
  • その他

 

がんの種類別

  • 多形膠芽腫
  • 星状細胞腫
  • 上衣腫
  • その他

 

作成者 エンド ユーザー

  • 病院
  • 専門クリニック
  • 外来手術センター
  • その他

 

国別

  • 中東およびアフリカ
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • 中東およびアフリカのその他の地域

 

記載されている企業

  1. Thermo Fisher Scientific Inc.
  2. Siemens Healthineers A
  3. GE ヘルスケア
  4. Biocept, Inc.
  5. Koninklijke Philips NV
  6. キヤノン メディカル システムズ
  7. 日立製作所
  8. >Neusoft Medical Systems

 

 

 

TABLE OF CONTENTS

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2          Brain Cancer Diagnostics Market – By Cancer Type

1.3.3          Brain Cancer Diagnostics Market – By End User

1.3.4          Middle East and Africa Brain Cancer Diagnostics Market – By Country

2.           Middle East and Africa Brain Cancer Diagnostics Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Middle East and Africa Brain Cancer Diagnostics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Brain Cancer Diagnostics Market- Middle East and Africa PEST Analysis

4.3          Expert Opinion

5.           Middle East and Africa Brain Cancer Diagnostics Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Increase in Prevalence of Brain Cancer

5.1.2          Rise in Number of Cigarette Smokers

5.2          Market Restraints

5.2.1          High Cost of Diagnosis

5.3          Future Trends

5.3.1          Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4          Impact Analysis

6.           Brain Cancer Diagnostics Market – Middle East and Africa Analysis

6.1          Middle East and Africa Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7.           Middle East and Africa Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1          Overview

7.2          Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3          Imaging Tests

7.3.1          Overview

7.3.2          Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3          MRI

7.3.3.1             Overview

7.3.3.2             MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4          CT Scan

7.3.4.1             Overview

7.3.4.2             CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5          Positron emission tomography (PET)

7.3.5.1             Overview

7.3.5.2             Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Lumbar Puncture

7.4.1          Overview

7.4.2          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Biopsy

7.5.1          Overview

7.5.2          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Molecular Testing

7.6.1          Overview

7.6.2          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7          Others

7.7.1          Overview

7.7.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Middle East and Africa Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1          Overview

8.2          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3          Astrocytomas

8.3.1          Overview

8.3.2          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Glioblastoma Multiforme

8.4.1          Overview

8.4.2          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Ependymomas

8.5.1          Overview

8.5.2          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6          Others

8.6.1          Overview

8.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Brain Cancer Diagnostics Market Analysis – By End user

9.1          Overview

9.2          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3          Hospitals

9.3.1          Overview

9.3.2          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4          Specialty Clinics

9.4.1          Overview

9.4.2          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5          Ambulatory Surgical Centers

9.5.1          Overview

9.5.2          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6          Others

9.6.1          Overview

9.6.2          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1        Middle East and Africa: Brain Cancer Diagnostics Market

10.1.1        Overview

10.1.2        Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.2.1          Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1           Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2           Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1     Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3           Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4           Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.2          UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1           UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2           UAE Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1     UAE Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3           UAE Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4           UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.3          South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1           South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2           South Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1     South Africa Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3           South Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4           South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

10.1.2.4          Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1           Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2           Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1     Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.3           Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4           Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on Middle East and Africa Brain Cancer Diagnostics Market

11.1        Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1        Overview

12.2        Growth Strategies Done by the Companies in the Market, (%)

12.1        Organic Developments

12.1.1        Overview

12.2        Inorganic Developments

12.2.1        Overview

13.        Company Profiles

13.1        THERMO FISHER SCIENTIFIC INC.

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        Siemens Healthineers AG

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        GE Healthcare

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        Biocept, Inc.

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        Koninklijke Philips N.V.

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        Canon Medical Systems

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

13.7        Hitachi, Ltd.

13.7.1        Key Facts

13.7.2        Business Description

13.7.3        Products and Services

13.7.4        Financial Overview

13.7.5        SWOT Analysis

13.7.6        Key Developments

13.8        Neusoft Medical Systems

13.8.1        Key Facts

13.8.2        Business Description

13.8.3        Products and Services

13.8.4        Financial Overview

13.8.5        SWOT Analysis

13.8.6        Key Developments

14.        Appendix

14.1        About the Insight Partners

14.2        Glossary of Terms

 


LIST OF TABLES

Table 1.              Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 2.              Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 3.              Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 4.              Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5.              UAE Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 6.              UAE Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 7.              UAE Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 8.              UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 9.              South Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)

Table 10.            South Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 11.            South Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 12.            South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13.            Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028  (USD Million)

Table 14.            Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 15.            Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 16.            Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17.            Organic Developments in the Brain Cancer Diagnostics Market

Table 18.            Inorganic Developments in the Brain Cancer Diagnostics Market

Table 19.            Glossary of Terms, Brain Cancer Diagnostics Market

 


LIST OF FIGURES

Figure 1.            Brain Cancer Diagnostics Market Segmentation

Figure 2.            Middle East and Africa Brain Cancer Diagnostics Market Overview

Figure 3.            Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4.            Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Brain Cancer Diagnostics Market - Middle East and Africa PEST Analysis

Figure 6.            Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7.            Middle East and Africa Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9.            Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.          MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18.          Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23.          Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.          Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.          Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.          Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.          Middle East and Africa: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 28.          Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 29.          Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30.          UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.          South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.          Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.          Impact of COVID-19 Pandemic in Middle East and African Country Markets

Figure 34.          Growth Strategies Done by the Companies in the Market, (%)

  1. Thermo Fisher Scientific Inc.
  2. Siemens Healthineers A
  3. GE Healthcare
  4. Biocept, Inc.
  5. Koninklijke Philips N.V
  6. Canon Medical Systems
  7. Hitachi, Ltd.
  8. Neusoft Medical Systems
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa brain cancer diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Middle East and Africa market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000